Detalles de la búsqueda
1.
Comparison of 3- to 6-Month Versus 12-Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-Eluting Stents With Ultrathin Struts: The HOST-IDEA Randomized Clinical Trial.
Circulation
; 147(18): 1358-1368, 2023 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36871230
2.
Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis.
Eur Heart J
; 44(15): 1360-1370, 2023 04 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36883613
3.
Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin in Patients with Dyslipidemia and Hypertension: A Multicenter Randomized Clinical Trial.
Curr Ther Res Clin Exp
; 100: 100735, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38380420
4.
Impact of diabetes on long-term outcomes of bifurcation percutaneous coronary intervention. An analysis from the BIFURCAT registry.
Catheter Cardiovasc Interv
; 102(4): 620-630, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37668085
5.
Real-world evidence of switching P2Y12 receptor-inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry.
BMC Cardiovasc Disord
; 23(1): 6, 2023 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36624388
6.
Durable Polymer Versus Biodegradable Polymer Drug-Eluting Stents After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: The HOST-REDUCE-POLYTECH-ACS Trial.
Circulation
; 143(11): 1081-1091, 2021 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33205662
7.
Angiographic complete revascularization versus incomplete revascularization in patients with diabetes mellitus.
Cardiovasc Diabetol
; 21(1): 56, 2022 04 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35439958
8.
Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial.
Lancet
; 396(10257): 1079-1089, 2020 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32882163
9.
The validation of the dual antiplatelet therapy score in East Asians receiving percutaneous coronary intervention with exclusively second generation drug-eluting stents.
Catheter Cardiovasc Interv
; 98(3): E332-E341, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33817960
10.
Procedural optimization of drug-coated balloons in the treatment of coronary artery disease.
Catheter Cardiovasc Interv
; 98(1): E43-E52, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33491857
11.
Comparison of 2-Stenting Strategies Depending on Sequence or Technique for Bifurcation Lesions in the Second-Generation Drug-Eluting Stent Eraã- Analysis From the COBIS (Coronary Bifurcation Stenting) III Registry.
Circ J
; 85(11): 1944-1955, 2021 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34078776
12.
Time Course and Risk Factors of New-Onset Complete Atrioventricular Block After Transcatheter Aortic Valve Implantation.
Int Heart J
; 62(5): 988-996, 2021 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34544968
13.
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
Circulation
; 140(23): 1921-1932, 2019 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31557056
14.
Association of Side-Branch Treatment and Patient Factors in Left Anterior Descending Artery True Bifurcation Lesions: Analysis from the GRAND-DES Pooled Registry.
J Interv Cardiol
; 2020: 8858642, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33447167
15.
Safety and Efficacy of Second-Generation Drug-Eluting Stents in Real-World Practice: Insights from the Multicenter Grand-DES Registry.
J Interv Cardiol
; 2020: 3872704, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32180687
16.
Clinical Implications of Bifurcation Angles in Left Main Bifurcation Intervention Using a Two-Stent Technique.
J Interv Cardiol
; 2020: 2475930, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32733170
17.
The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era.
J Interv Cardiol
; 2019: 3270132, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31772522
18.
Randomized Prospective Comparison of Everolimus-Eluting vs. Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Interventionã- 3-Year Clinical Outcomes of the EXCELLENT Randomized Trial.
Circ J
; 82(6): 1566-1574, 2018 05 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28966335
19.
The natural course of nonculprit coronary artery lesions; analysis by serial quantitative coronary angiography.
BMC Cardiovasc Disord
; 18(1): 130, 2018 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29954346
20.
Bioresorbable Vascular Scaffoldsã- Are We Facing a Time of Crisis or One of Breakthrough?
Circ J
; 81(8): 1065-1074, 2017 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28680011